What is α1-Antitrypsin? α1-Antitrypsin (AAT) is a glycoprotein produced primarily by the liver, functioning as a protease inhibitor that protects tissues from enzymes like neutrophil elastase. It is a key biomarker for diagnosing α1-antitrypsin deficiency, a genetic condition associated with lung (e.g., emphysema) and liver diseases. Measuring AAT levels helps assess deficiency risk and guide treatment.
Definition: The α1-Antitrypsin Unit Converter converts AAT concentrations between various units, enabling standardization of laboratory results for clinical use.
Purpose: It assists clinicians and researchers in interpreting AAT levels across different measurement units (e.g., mmol/L to g/L), ensuring accurate diagnosis and management of AAT deficiency and related disorders.
Converting AAT concentrations between units is critical for:
Abnormal Levels: Low AAT levels indicate α1-antitrypsin deficiency, increasing the risk of emphysema, chronic obstructive pulmonary disease (COPD), or liver cirrhosis. Elevated levels may occur in inflammation, pregnancy, or acute-phase reactions.
Normal Ranges:
Interferences:
Q: Why are there different units for AAT?
A: Different units reflect varying standards; µmol/L is the SI unit, while g/L and mg/mL are commonly used in clinical practice.
Q: What is a normal AAT level?
A: Normal AAT is typically 0.9–2.0 g/L (18–39 µmol/L). Levels vary by context—consult a healthcare provider for interpretation.
Q: Can this converter be used for other proteins?
A: No, this converter is specific to AAT; other proteins have different conversion factors—consult a healthcare provider for accuracy.